Cargando…
Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915032/ https://www.ncbi.nlm.nih.gov/pubmed/27312972 http://dx.doi.org/10.1038/ncomms11915 |
_version_ | 1782438632009760768 |
---|---|
author | Viana da Silva, Silvia Haberl, Matthias Georg Zhang, Pei Bethge, Philipp Lemos, Cristina Gonçalves, Nélio Gorlewicz, Adam Malezieux, Meryl Gonçalves, Francisco Q. Grosjean, Noëlle Blanchet, Christophe Frick, Andreas Nägerl, U Valentin Cunha, Rodrigo A. Mulle, Christophe |
author_facet | Viana da Silva, Silvia Haberl, Matthias Georg Zhang, Pei Bethge, Philipp Lemos, Cristina Gonçalves, Nélio Gorlewicz, Adam Malezieux, Meryl Gonçalves, Francisco Q. Grosjean, Noëlle Blanchet, Christophe Frick, Andreas Nägerl, U Valentin Cunha, Rodrigo A. Mulle, Christophe |
author_sort | Viana da Silva, Silvia |
collection | PubMed |
description | Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model of AD amyloidosis, we show that associative long-term synaptic potentiation (LTP) is abolished in CA3 pyramidal cells at an early stage. This is caused by activation of upregulated neuronal adenosine A(2A) receptors (A(2A)R) rather than by dysregulation of NMDAR signalling or altered dendritic spine morphology. Neutralization of A(2A)R by acute pharmacological inhibition, or downregulation driven by shRNA interference in a single postsynaptic neuron restore associative CA3 LTP. Accordingly, treatment with A(2A)R antagonists reverts one-trial memory deficits. These results provide mechanistic support to encourage testing the therapeutic efficacy of A(2A)R antagonists in early AD patients. |
format | Online Article Text |
id | pubmed-4915032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49150322016-06-29 Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors Viana da Silva, Silvia Haberl, Matthias Georg Zhang, Pei Bethge, Philipp Lemos, Cristina Gonçalves, Nélio Gorlewicz, Adam Malezieux, Meryl Gonçalves, Francisco Q. Grosjean, Noëlle Blanchet, Christophe Frick, Andreas Nägerl, U Valentin Cunha, Rodrigo A. Mulle, Christophe Nat Commun Article Synaptic plasticity in the autoassociative network of recurrent connections among hippocampal CA3 pyramidal cells is thought to enable the storage of episodic memory. Impaired episodic memory is an early manifestation of cognitive deficits in Alzheimer's disease (AD). In the APP/PS1 mouse model of AD amyloidosis, we show that associative long-term synaptic potentiation (LTP) is abolished in CA3 pyramidal cells at an early stage. This is caused by activation of upregulated neuronal adenosine A(2A) receptors (A(2A)R) rather than by dysregulation of NMDAR signalling or altered dendritic spine morphology. Neutralization of A(2A)R by acute pharmacological inhibition, or downregulation driven by shRNA interference in a single postsynaptic neuron restore associative CA3 LTP. Accordingly, treatment with A(2A)R antagonists reverts one-trial memory deficits. These results provide mechanistic support to encourage testing the therapeutic efficacy of A(2A)R antagonists in early AD patients. Nature Publishing Group 2016-06-17 /pmc/articles/PMC4915032/ /pubmed/27312972 http://dx.doi.org/10.1038/ncomms11915 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Viana da Silva, Silvia Haberl, Matthias Georg Zhang, Pei Bethge, Philipp Lemos, Cristina Gonçalves, Nélio Gorlewicz, Adam Malezieux, Meryl Gonçalves, Francisco Q. Grosjean, Noëlle Blanchet, Christophe Frick, Andreas Nägerl, U Valentin Cunha, Rodrigo A. Mulle, Christophe Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors |
title | Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors |
title_full | Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors |
title_fullStr | Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors |
title_full_unstemmed | Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors |
title_short | Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors |
title_sort | early synaptic deficits in the app/ps1 mouse model of alzheimer's disease involve neuronal adenosine a(2a) receptors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915032/ https://www.ncbi.nlm.nih.gov/pubmed/27312972 http://dx.doi.org/10.1038/ncomms11915 |
work_keys_str_mv | AT vianadasilvasilvia earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT haberlmatthiasgeorg earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT zhangpei earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT bethgephilipp earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT lemoscristina earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT goncalvesnelio earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT gorlewiczadam earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT malezieuxmeryl earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT goncalvesfranciscoq earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT grosjeannoelle earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT blanchetchristophe earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT frickandreas earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT nagerluvalentin earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT cunharodrigoa earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors AT mullechristophe earlysynapticdeficitsintheappps1mousemodelofalzheimersdiseaseinvolveneuronaladenosinea2areceptors |